Progressive multifocal leukoencephalopathy in transplant recipients

Annals of Neurology

Volumn 70, Issue 2, 2011, Pages 305-322

  Mateen, Farrah J ^a,b   Muralidharan, Rajanandini ^d   Carone, Marco ^c   Van De Beek, Diederik ^e   Harrison, Daniel M ^a   Aksamit, Allen J ^d   Gould, Mary S ^f   Clifford, David B ^f   Nath, Avindra ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d MAYO CLINIC   (United States)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; ALKYLATING AGENT; AZATHIOPRINE; CIDOFOVIR; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; DEXAMETHASONE; GANCICLOVIR; INTERLEUKIN 2; LEFLUNOMIDE; MEFLOQUINE; METHOTREXATE; MIRTAZAPINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PEGINTERFERON ALPHA; PREDNISONE; PROBENECID; RAPAMYCIN; RITUXIMAB; TACROLIMUS; THALIDOMIDE; TILORONE;

ADULT; AGED; ARTICLE; AUTOPSY; BONE MARROW TRANSPLANTATION; BRAIN BIOPSY; COHORT ANALYSIS; CONTINUOUS INFUSION; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FATALITY; FEMALE; GRAFT RECIPIENT; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LOADING DRUG DOSE; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; COHORT STUDIES; FEMALE; HUMANS; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MALE; MIDDLE AGED; PUBMED; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TRANSPLANTS; YOUNG ADULT;

EID: 80051496805     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22408     Document Type: Article

References (81)

1. Johnson RT,. Acute disseminated encephalomyelitis and progressive multifocal leukoencephalopathy. In ed., Shapira AH, ed. Neurology and clinical neuroscience. Philadelphia: Elsevier, 2007: 1060-1062.
2. Egli A, Infanti L, Dumoulin A, et al. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis 2009; 199: 837-846.
3. Åström KE, Mancall EL, Richardson EP Jr,. Progressive multifocal leuko-encephalopathy: a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease. Brain 1958; 81: 93-111.
4. Manz HJ, Dinsdale HB, Morrin PA,. Progressive multifocal leukoencephalopathy after renal transplantation. Ann Intern Med 1971; 75: 77-81.
5. United Network for Organ Sharing. Available at: Last accessed March 22, 2011.
6. Khanna N, Elzi L, Mueller NJ, et al. Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV cohort study. Clin Infect Dis 2009; 48: 1459-1466.
7. Clifford DB, Deluca A, Simpson DM, et al. Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases. Lancet Neurol 2010; 9: 438-446.
8. Gheuens S, Pierone G, Peeters P, Koralnik IJ,. Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression. J Neurol Neurosurg Psych 2010; 81: 247-254.
9. Carson KR, Evens AM, Richey EA, et al. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the research on adverse drug events and reports project. Blood 2009; 113: 4834-4840.
10. Marzocchetti A, Tompkins T, Clifford DB, et al. Determinants of survival in progressive multifocal leukoencephalopathy. Neurology 2009; 73: 1551-1558.
11. Shelburne SA, Hamill RJ, Rodriguez-Barradas MC, et al. Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active retroviral therapy. Medicine (Baltimore) 2002; 81: 213-227. (Pubitemid 34507208)
12. Rosner BA,. Fundamentals of biostatistics. 6th ed. Pacific Grove, CA: Duxbury Press, 2006.
13. Højsgaard S, Halekoh U, Yan J,. The R package geepack for generalized estimating equations. J Stat Softw 2005; 15: 1-11.
14. Liang KY, Zeger SL,. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73: 13.
15. R Development Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2008.
16. Stata Corp. Stata (v.11). College Station, TX: Stata Corp, 2009.
17. Agresti A,. Categorical data analysis. Hoboken, NJ: John Wiley & Sons, 2002.
18. Brown GW, Mood AM,. On median tests for linear hypotheses. Proceedings of the Second Berkeley Symposium on Mathematical Statistics and Probability. Berkeley, CA: University of California Press, 1951: 159-166.
19. Kaplan, EL, Meier, P,. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
20. Brookmeyer R, Crowley J,. A confidence interval for the median survival time. Biometrics 1982; 38: 29-41.
21. Hess K, Gentleman R,. Hazard function estimation in survival analysis. R package version 1.2.4, 2009.
22. Mueller HG, Wang JL,. Hazard rates estimation under random censoring with varying kernels and bandwidths. Biometrics 1994; 50: 61-76.
23. Mateen FJ, Dierkhising RA, Rabinstein AA, et al. Neurological complications following adult lung transplantation. Am J Transplant 2010; 10: 908-914.
24. van de Beek D, Patel R, Daly RC, et al. Central nervous system infections in heart transplant recipients. Arch Neurol 2007; 64: 1715-1720. (Pubitemid 350254932)
25. Aksamit AJ Jr, de Groen PC,. Cyclosporine-related leukoencephalopathy and PML in a liver transplant recipient. Transplantation 1995; 60: 874-876.
26. Yehia B, Davison A, Sisson S,. Transplant troubles. Am J Med 2009; 122: 629-631.
27. van de Beek D, Kremers W, Daly RC, et al. Effect of neurologic complications on outcome after heart transplant. Arch Neurol 2008; 65: 226-231. (Pubitemid 351240785)
28. Ouwens JP, Haaxma-Reiche H, Verschuuren EA, et al. Visual symptoms after lung transplantation: a case of progressive multifocal leukoencephalopathy. Transpl Infect Dis 2000; 2: 29-32. (Pubitemid 30139962)
29. Shitrit D, Nirit L, Shiran SI, et al. Progressive multifocal leukoencephalopathy in a lung transplant recipient. J Heart Lung Transplant 2003; 22: 946-950. (Pubitemid 36945495)
30. Waggoner J, Martinu T, Palmer SM,. Progressive multifocal leukoencephalopathy following heightened immunosuppression after lung transplant. J Heart Lung Transplant 2009; 28: 395-398.
31. Hall WA, Martinez J, Dummer JS,. Progressive multifocal leukoencephalopathy after cardiac transplantation. Neurology 1988; 38: 995-996.
32. Flomenbaum MA, Jarcho JA, Schoen FJ,. Progressive multifocal leukoencephalopathy fifty-seven months after heart transplantation. J Heart Lung Transplant 1991; 10: 888-893.
33. Lewis AR, Kline LB, Pinkard NB,. Visual loss due to progressive multifocal leukoencephalopathy in a heart transplant patient. J Clin Neuroophthalmol 1993; 13: 237-241. (Pubitemid 24012959)
34. McCalmont V, Bennett K,. Progressive multifocal leukoencephalopathy; a case study. Prog Transplant 2007; 17: 157-160. (Pubitemid 46897066)
35. Worthmann F, Türker T, Müller AR, et al. Progressive multifocal leukoencephalopathy after orthotopic liver transplantation. Transplantation 1993; 57: 1268-1270.
36. Bronster DJ, Lidov MW, Wolfe D, Schwartz ME, Miller CM,. Progressive multifocal leukoencephalopathy after orthotopic liver transplantation. Liver Transpl Surg 1995; 1: 371-372.
37. Boulton-Jones JR, Fraser-Moodie C, Ryder SD,. Long term survival from progressive multifocal leucoencephalopathy after liver transplantation. J Hepatol 2001; 35: 828-831.
38. Koralnik IJ, Schellingerhout D, Frosch MP,. Case 14-2004: a 66-year-old man with progressive neurologic deficits. N Engl J Med 2004; 350: 1882-1893. (Pubitemid 38917254)
39. Lima MA, Hanto DW, Curry MP, Wong MT, et al. Atypical radiological presentation of progressive multifocal leukoencephalopathy following liver transplantation. J Neurovirol 2005; 11: 46-50. (Pubitemid 40458370)
40. Alibert S, Gérolami R, Tammam D, et al. [Progressive multifocal leukoencephalopathy secondary to JC virus infection after liver transplantation and treatment of recurrent hepatitis C]. Gastroenterol Clin Biol 2006; 30: 473-475. [French] (Pubitemid 44020153)
41. ZuRhein GM, Varakis J,. Letter: Progressive multifocal leukoencephalopathy in a renal allograft recipient. N Engl J Med 1974; 291: 798.
42. Legrain M, Graveleau J, Brion S, et al. [Progressive multifocal leukoencephalopathy following kidney transplantation]. J Neurol Sci 1974; 23: 49-62. [French]
43. McCormick WF, Schochet SS, Sarles HE, Calverley JR,. Progressive multifocal leukoencephalopathy in renal transplant recipients. Arch Intern Med 1976; 136: 829-834.
44. Selhorst JB, Ducy KF, Thomas JM, Regelson W,. PML: remission and immunologic reversals PP.26. Neurology 1978; 28: 337.
45. Egan JD, Ring BL, Reding MJ, Wells IC,. Reticulum cell sarcoma and progressive multifocal leukoencephalopathy following renal transplantation. Transplantation 1980; 29: 84-86. (Pubitemid 10072456)
46. Ho K, Garancis JC, Paegle RD, et al. Progressive multifocal leukoencephalopathy and malignant lymphoma of the brain in a patient with immunosuppressive therapy. Acta Neuropathol (Berl) 1980; 52: 81-83. (Pubitemid 10011163)
47. Reznik M, Halleux J, Urbain E, et al. [Progressive multifocal leukoencephalopathy after renal transplantation. Report of two cases]. Acta Neurol Belg 1981; 81: 205-214. [French] (Pubitemid 12200651)
48. Holzhausen V, Mampel E, Koall W, et al. [Progressive multifocal leukoencephalopathy as a complication of immunosuppression in kidney transplantation]. Z Gesamte Inn Med 1977; 32: 578-581. [German]
49. Saxton CR, Gailiunas P Jr, Helderman JH, et al. Progressive multifocal leukoencephalopathy in a renal transplant recipient. Am J Med 1984; 77: 333-337.
50. Garcia JH, Pearson J, Bonnin J, Gupta KL,. Medical pathology conference: deteriorating neurologic function in a 28-year-old renal transplant recipient. Ala J Med Sci 1985; 22: 208-214.
51. Embrey JR, Silva FG, Helderman H, et al. Long-term survival and late development of bladder cancer in renal transplant patient with progressive multifocal leukoencephalopathy. J Urol 1988; 139: 580-581. (Pubitemid 18082900)
52. Táborský P, Hrabánek J, Jirásek A, Matl I,. [Progressive multifocal leukoencephalopathy in a female patient after kidney transplantation] Vnitr Lek 1998; 44: 108-110. [Czech]
53. Berner B, Krieter DH, Wolfgang Rumpf K, et al. Progressive multifocal leukoencephalopathy in a renal transplant patient diagnosed by JCV-specific DNA amplification and an intrathecal humoral immune response to recombinant virus protein 1. Nephrol Dial Transplant 1999; 14: 462-465. (Pubitemid 29062817)
54. Phillips T, Jacobs R, Ellis EN,. Polyoma nephropathy and progressive multifocal leukoencephalopathy in a renal transplant recipient. J Child Neurol 2004; 19: 301-304. (Pubitemid 38660215)
55. Crowder CD, Gyure KA, Drachenberg CB, et al. Successful outcome of progressive multifocal leukoencephalopathy in a renal transplant patient. Am J Transplant 2005; 1151-1158. (Pubitemid 40571268)
56. Manfro RC, Vedolin L, Cantarelli M, et al. Progressive multifocal leukoencephalopathy in a kidney transplant recipient after conversion to mycophenolic acid therapy. Transpl Infect Dis 2009; 11: 189-190.
57. Epker JL, van Biezen P, van Daele PL, et al. Progressive multifocal leukoencephalopathy, a review and an extended report of five patients with different immune compromised states. Eur J Intern Med 2009; 20: 261-267.
58. Mesquita R, Parravicini C, Björkholm M, et al. Macrophage association of polyoma virus in progressive multifocal leukoencephalopathy: an immunohistochemical and ultrastructural study. APMIS 1992; 100: 993-1000. (Pubitemid 23012563)
59. O'shaughnessy D, Goldman JM, Roddie M, Schofield JB,. Dizziness and confusion after bone marrow transplantation. BMJ 1994; 309: 262-265.
60. Seong D, Bruner JM, Lee KH, et al. Progressive multifocal leukoencephalopathy after autologous bone marrow transplantation in a patient with chronic myelogenous leukemia. Clin Infect Dis 1996; 23: 402-403. (Pubitemid 26264934)
61. Przepiorka D, Jaeckle KA, Birdwell RR, et al. Successful treatment of progressive multifocal leukoencephalopathy with low-dose interleukin-2. Bone Marrow Transplant 1997; 20: 983-987. (Pubitemid 27510963)
62. Coppo P, Laporte JPh, Aoudjhane M, et al. Progressive multifocal leucoencephalopathy with peripheral demyelinating neuropathy after autologous bone marrow transplantation for acute myeloblastic leukemia (FAB5). Bone Marrow Transplant 1999; 23: 401-403. (Pubitemid 29105966)
63. Re D, Bamborschke S, Feiden W, et al. Progressive multifocal leukoencephalopathy after autologous bone marrow transplantation and alpha-interferon immunotherapy. Bone Marrow Transplant 1999; 23: 295-298. (Pubitemid 29078345)
64. Owen RG, Patmore RD, Smit GM, Barnard DL,. Cytomegalovirus-induced T-cell proliferation and the development of progressive multifocal leucoencephalopathy following bone marrow transplantation. Br J Haematol 1995; 89: 196-198.
65. Goldberg SL, Pecora AL, Alter RS, et al. Unusual viral infections (progressive multifocal leukoencephalopathy and cytomegalovirus disease) after high-dose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximab. Blood 2002; 99: 1486-1488. (Pubitemid 34547110)
66. Osorio S, de la Cámara R, Colbano N, et al. Progressive multifocal leukoencephalopathy after stem cell transplantation, unsuccessfully treated with cidofovir. Bone Marrow Transplant 2002; 30: 963-966. (Pubitemid 36097487)
67. Buckanovich RJ, Liu G, Stricker C, et al. Nonmyeloablative allogeneic stem cell transplantation for refractory Hodgkin's lymphoma complicated by interleukin-2 responsive progressive multifocal leukoencephalopathy. Ann Hematol 2002; 81: 410-413. (Pubitemid 36067653)
68. Steurer M, Clausen J, Gotwald T, et al. Progressive multifocal leukoencephalopathy after allogeneic stem cell transplantation and posttransplantation rituximab. Transplantation 2003; 76: 435-448.
69. Gabriel IH, Olavarria E, Jones RR, et al. Graft versus lymphoma effect after early relapse following reduced-intensity sibling allogeneic stem cell transplantation for relapsed cytotoxic variant of mycosis fungoides. Bone Marrow Transplant 2007; 40: 401-403. (Pubitemid 47202430)
70. Focosi D, Fazzi R, Montanaro D, et al. Progressive multifocal leukoencephalopathy in a haploidentical stem cell transplant recipient: a clinical, neuroradiological and virological response after treatment with risperidone. Antiviral Res 2007; 74: 156-158. (Pubitemid 46436167)
71. Kharfan-Dabaja MA, Ayala E, Greene J, et al. Two cases of progressive multifocal leukoencephalopathy after allogeneic hematopoietic cell transplantation and a review of the literature. Bone Marrow Transplant 2007; 39: 101-107. (Pubitemid 46085228)
72. Yasuda Y, Yabe H, Inoue H, et al. Progressive multifocal leukoencephalopathy after allogeneic bone marrow transplantation for Wiskott-Aldrich syndrome. Pediatr Int 2008; 50: 238-240. (Pubitemid 351414775)
73. Sheikh SI, Stemmer-Rachamimov A, Attar EC,. Autopsy diagnosis of progressive multifocal leukoencephalopathy with JC virus-negative CSF after cord blood stem-cell transplantation. J Clin Oncol 2009; 27: e46-e47.
74. Chowdhary S, Chamberlain M,. A progressive neurologic disorder with multiple CNS lesions: a neuroimaging clinicopathologic correlation. Progressive multifocal leukoencephalopathy (PML). J Neuroimaging 2008; 18: 340-344.
75. Pelosini M, Focosi D, Rita F, et al. Progressive multifocal leukoencephalopathy; report of three cases in HIV-negative hematological patients and review of the literature. Ann Hematol 2002; 87: 405-412.
76. Fianchi L, Colosimo C, De Luca A, et al. Atypical presentation of progressive multifocal leukoencephalopathy in a multiple myeloma patient after auto-SCT successfully treated with combination therapy. Bone Marrow Transplant 2010; 45: 1668-1670.
77. Tuccori M, Focosi D, Maggi F, et al. Progressive multifocal leukoencephalopathy: a report of three cases in HIV-negative patients with non-Hodgkin's lymphomas treated with rituximab. Ann Hematol 2010; 89: 519-522.
78. Yousry TA, Major EO, Ryschkewitsch C, et al. Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. N Engl J Med 2006; 354: 924-933.
79. Molloy ES, Calabrese LH,. Progressive multifocal leukoencephalopathy a national estimate of frequency in systemic lupus erythematosus and other rheumatic diseases. Arthritis Rheum 2009; 60: 3761-3765.
80. De Luca A, Ammassari A, Cingolani A, et al. Disease progression and poor survival of AIDS-associated progressive multifocal leukoencephalopathy despite highly active antiretroviral therapy. AIDS 1998; 12: 1937-1938. (Pubitemid 28454467)
81. Amend KL, Turnbull B, Foskett N, et al. Incidence of progressive multifocal leukoencephalopathy in patients without HIV. Neurology 2010; 75: 1326-1332.